LiveMint-Keywords


Fresenius seeks more time to sell its Dabur shares C.H. Unnikishnan 12:36 AM \| November 26,2008 The firm will lose at least Rs6 crore if it sells the 1.5 million shares, making up 0.89% of its stake, at current prices FIND MORE ARTICLES ON: Fresenius Kabi Singapore Dabur Pharma Sebi Rakesh Bhargava Shares APP Pharmaceuticals
Doubting Dabur 12:05 AM \| April 22,2008 Even if companies must keep the details of talks under wraps for strategic reasons, they are responsible to investors, as such deals clearly move markets FIND MORE ARTICLES ON: Dabur Pharma Ltd Fresenius Kabi Sebi Market
No plans to delist Dabur Pharma: Fresenius Reuters 02:55 PM \| April 21,2008 German acquirer will make a mandatory offer to acquire another 20% of the company in 4-6 weeks FIND MORE ARTICLES ON: Fresenius Kabi Dabur Pharma Acquisition Delisting Anti-cancer drug